Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2009
08/06/2009WO2009070693A3 Modulators of ocular oxidative stress
08/06/2009WO2009054952A3 Small molecule inhibitors of parp activity
08/06/2009WO2009053999A3 Sulfoximine derivatives as factor xa inhibitors
08/06/2009US20090198066 Amorphous esomeprazole hydrate
08/06/2009US20090198060 Nitrogen-containing heterocyclic compound and thrombopoietin receptor activator
08/06/2009US20090198059 Process for the preparation of polymorphs, solvates of aripiprazole using aripirazole acid salts
08/06/2009US20090198057 Certain Chemical Entities, Compositions, and Methods
08/06/2009US20090198052 Method for preparing optically active piperidine compounds
08/06/2009US20090197919 Novel Method for Preparation of Ammonium Salts of Esomeprazole
08/06/2009US20090197915 Sigma receptor compounds
08/06/2009US20090197914 Piperidine Derivatives, Their Process for Preparation, Their Use as Therapeutic Agents and Pharmaceutical Compositions Containing Them
08/06/2009US20090197901 Variolin derivatives and their use as antitumor agents
08/06/2009US20090197894 Nicotinamide derivatives and their use as therapeutic agents
08/06/2009US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists
08/06/2009US20090197886 Hexahydro-cycloheptapyrazole cannabinoid modulators
08/06/2009US20090197884 Compounds Useful as Antagonists of CCR2
08/06/2009US20090197883 Diphenyl Substituted Cycloalkanes, Compositions Containing Such Compounds and Methods Of Use
08/06/2009US20090197882 Indazole derivatives for the treatment of hsp90-induced diseases
08/06/2009US20090197879 Vanilloid receptor ligands and their use in treatments
08/06/2009US20090197862 2-aminopyridine kinase inhibitors
08/06/2009US20090197860 Biaryl substituted diazabicycloalkane derivatives
08/06/2009US20090197859 Pyridinyl Amides for the Treatment of CNS and Metabolic Disorders
08/06/2009US20090196912 Pyridinylamines
08/06/2009US20090196886 Vaccine against nicotine addiction
08/06/2009CA2715069A1 Novel heterocycles
08/06/2009CA2713553A1 Pyrazine derivatives and their use as protein kinase inhibitors
08/06/2009CA2712885A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
08/06/2009CA2712854A1 Cyclic indole-3-carboxamides, their preparation and their use as pharmaceuticals
08/05/2009EP2085395A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
08/05/2009EP2085391A2 Inhibitors of factor XA and other serine proteases involved in the coagulation cascade
08/05/2009EP2085390A1 Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors
08/05/2009EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents
08/05/2009EP2085383A1 Piperidine derivatives or salts thereof
08/05/2009EP2084152A2 Substituted 4-imidazoles
08/05/2009EP2084151A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
08/05/2009EP2084150A1 Process for the preparation of tertiary n-allyl sterically hindered amines
08/05/2009EP2084149A1 Organic compounds
08/05/2009EP2084148A1 Fungicide n-cycloalkyl-carboxamide, thiocarboxamide and n-substituted-carboximidamide derivatives
08/05/2009EP2084147A1 Heterocyclic fxr binding compounds
08/05/2009EP2084146A1 Cyclic derivatives as modulators of chemokine receptor activity
08/05/2009EP2084145A2 (s)-phenyl(heterocycle)methanol-based compounds, compositions comprising them and methods of their use
08/05/2009EP2084144A2 Synthesis of piperazines, piperidines and related compounds
08/05/2009EP2084134A1 Chemical compounds
08/05/2009EP2084131A1 Indole and benzofuran 2-carboxamide derivatives
08/05/2009EP1984354B1 Pesticides containing a bicyclic bisamide structure
08/05/2009EP1924560B1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
08/05/2009EP1877398B1 Quinazoline derivatives as egf and/or erbb2 tyrosine kinase inhibitors
08/05/2009EP1877397B1 Quinazoline derivatives as inhibitors of egf and/or erbb2 receptor tyrosine kinase
08/05/2009EP1781606B1 Azetidine derivatives as ccr-3 receptor antagonists
08/05/2009EP1753721B1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
08/05/2009EP1742707A4 Treatment of cns disorders using cns target modulators
08/05/2009EP1713803B1 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments
08/05/2009EP1699454B1 Pyrazole derivatives and use thereof as orexin receptor antagonists
08/05/2009EP1631292B1 4-anilino-quinazoline derivatives as antiproliferative agents
08/05/2009EP1531822B1 1-aryl-4-substituted piperazine derivatives for use as ccr1 antagonists for the treatment of inflammation and immune disorders
08/05/2009EP1509506B1 Pyridazine derivatives
08/05/2009EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors
08/05/2009EP1496052B1 Novel aminobenzamide derivative
08/05/2009EP1475370B1 Optically active azole derivative and process for producing the same
08/05/2009EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine
08/05/2009EP1445253B1 4,4-difluoro-1, 2, 3, 4-tetrahydro-5h-1-benzazepine derivatives or salts thereof
08/05/2009EP1357111B1 2-pyridone derivatives having affinity for cannabinoid type 2 receptor
08/05/2009EP1296974B1 2-cyanopyrrolidine derivatives and their use as medicaments
08/05/2009EP0813424B2 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
08/05/2009CN101501025A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
08/05/2009CN101501024A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
08/05/2009CN101501023A Phenyl substituted heteroaryl-derivatives and use thereof as anti-tumor agents
08/05/2009CN101501022A Benzimidazole derivatives which are to be used as anatgonis for the CB1-receptor
08/05/2009CN101501021A Muscarinic receptor agonists that are effective in the treatment of pain, alzheimer's disease and schizophrenia
08/05/2009CN101501020A Nitrate esters of piperidines
08/05/2009CN101501019A Short-acting benzodiazepine salts and their polymorphic forms
08/05/2009CN101501008A Arylpiperazine derivatives and uses thereof
08/05/2009CN101501007A Quinazoline derivative
08/05/2009CN101501006A Pyridinone and pyridazinone derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)
08/05/2009CN101501004A Compounds and compositions as HEDGEHOG signaling pathway modulators
08/05/2009CN101500995A 1-oxo-isoindoline compounds for the treatment of spinal muscular atrophy and other uses
08/05/2009CN101500994A 1,3-disubstituted 4-methyl-1h-pyrrole-2-carboxamides and their use for the manufacture of medicaments
08/05/2009CN101500993A 2-aminocarbonylphenylamino-2-phenilacetamides as factor VIIa inhibitors useful as anticoagulants
08/05/2009CN101497606A Preparation of rupatadine or salt thereof
08/05/2009CN101497605A Benzimidazole derivative containing alkoxy substituted pyridine
08/05/2009CN101497604A Benzimidazole derivative containing alkoxy acetamide substituted pyridine
08/05/2009CN101497603A Benzimidazole derivative containing alkoxy alkanamine oxyl substituted pyridine
08/05/2009CN101497602A Anthranilic acid compound and use thereof
08/05/2009CN101497601A Process for synthesizing imatinib
08/05/2009CN101497584A Isoquinoline-3-formyl amino acid formyl amino acid benzyl ester, as well as preparation and use thereof
08/05/2009CN100522958C Preparation and use of 2-substituted-5-oxo-3- pyrazolidinecarboxylates
08/05/2009CN100522949C Piperazinedione compounds
08/05/2009CN100522947C CCK-1 receptor modulators
08/05/2009CN100522934C Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
08/05/2009CN100522166C (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/05/2009CN100522164C Method of treating of demyelinating diseases or conditions
08/04/2009US7569852 Transition metal complex and light-emitting device
08/04/2009US7569697 Benzimidazole compound crystal
08/04/2009US7569696 Process for producing crystal
08/04/2009US7569688 Propane-1, 3-dione derivative
08/04/2009US7569678 Protease inhibitor conjugates and antibodies useful in immunoassay
08/04/2009US7569595 Selective to alpha2B and/or alpha2C adrenergic receptors, minimal cardivascular and/or sedatory activity; treating pain, visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
08/04/2009US7569593 Compounds and compositions as protein kinase inhibitors
08/04/2009US7569592 Heteroaryl substituted pyrazole modulators of metabotropic glutamate receptor-5
08/04/2009US7569591 topoisomerase inhibitors such as [5-(4-Cyclopropylcarbamoyl-imidazol-1-yl)-7-pyrimidin-2-yl-1H-benzoimidazol-2-yl]-carbamic acid ethyl ester, used for prophylaxis of bacterial infections in mammals